Quick Answer
PULSE BIOSCIENCES, INC. reported Stockholders Equity of $80.66 million for the year ending 2025.
- PULSE BIOSCIENCES, INC. showed a decrease of -29.8% in Stockholders Equity from 2024 to 2025.
- This data is from PULSE BIOSCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2016: $12.17 million | Q2 2016: $30.47 million | Q3 2016: $27.86 million | Q1 2017: $27.33 million | Q2 2017: $24.16 million | Q3 2017: $49.94 million | Q1 2018: $41.10 million | Q2 2018: $35.05 million | Q3 2018: $28.07 million | Q1 2019: $59.11 million | Q2 2019: $49.86 million | Q3 2019: $40.98 million | Q1 2020: $21.77 million | Q2 2020: $42.33 million | Q3 2020: $32.70 million | Q1 2021: $20.40 million | Q2 2021: $59.75 million | Q3 2021: $47.39 million | Q4 2021: $44.36 million | Q1 2022: $20.80 million | Q2 2022: $23.42 million | Q3 2022: $6.19 million | Q1 2023: -$10.67 million | Q2 2023: $60.50 million | Q3 2023: $52.15 million | Q1 2024: $36.29 million | Q2 2024: $26.97 million | Q3 2024: $79.13 million | Q1 2025: $118.45 million | Q2 2025: $104.49 million | Q3 2025: $92.69 million.
- Over the full 12 years of available data (2014 to 2025), PULSE BIOSCIENCES, INC.'s Stockholders Equity has grown by 401.8%.
- Historical annual values: Fiscal year 2025: $80.66 million | Fiscal year 2024: $114.86 million | Fiscal year 2023: $44.36 million | Fiscal year 2022: -$2.25 million | Fiscal year 2021: $35.69 million | Fiscal year 2020: $22.89 million | Fiscal year 2019: $30.74 million | Fiscal year 2018: $66.33 million | Fiscal year 2017: $46.00 million | Fiscal year 2016: $25.30 million | Fiscal year 2015: $13.67 million | Fiscal year 2014: $16.07 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: